Overall these results suggest that circadian clock characteristics are altered upon thyroid nodule malignant transformation/progression and that changes in clock gene expression profiles may be potentially employed in clinics as potential biomarkers for FTCs and disease progression (Figure 2). Here, CLOCK is linked to thyroid nodule.